drugset / Trial / NCT02179008

Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT02179008

Phase 2 Completed 184 enrolled Santen Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of five concentrations of DE-117 ophthalmic solution.

Timeline

Start
2014-06
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule Other
Subject omidenepag isopropyl Small molecule Other